Evidence map›Paper›PMID 37032897›Full record

ArticleFrontiers in microbiology2023

Two new siderophores produced by

Camille Grosse, Nathalie Brandt, Pierre Van Antwerpen, René Wintjens, Sandra Matthijs

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
8.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Discovery and Comprehensive Characterization ofInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Proteomic and Secretomic Response of an AfricanJournal of proteome research · 2026
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Expanding theFrontiers in microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Camille GrosseUnité de Recherche NaturaMonas, Institut de Recherche LABIRIS, Brussels, Belgium.
Nathalie BrandtUnité de Recherche NaturaMonas, Institut de Recherche LABIRIS, Brussels, Belgium.
Pierre Van AntwerpenRD3 - Pharmacognosy, Bioanalysis and Drug Discovery and Analytical Platform of the Faculty of Pharmacy, Université Libre de Bruxelles, Brussels, Belgium.
René WintjensUnité Microbiologie, Chimie Bioorganique et Macromoléculaire, Department of Research in Drug Development (RD3), Faculty of Pharmacy, Université Libre de Bruxelles, Brussels, Belgium.
Sandra MatthijsUnité de Recherche NaturaMonas, Institut de Recherche LABIRIS, Brussels, Belgium.
Directorate-General Joint Research Centre · BEUniversité Libre de Bruxelles · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Results: In this study, the soil bacterium Conclusion: Altogether, we have demonstrated here that besides pyoverdine,

Indexed as

antimicrobialcompetitiongene regulationGlobisporangiumiron uptakenatural productsPseudomonassiderophore

Identifiers

PMID37032897
PMCPMC10080011
OpenAlexW4360868793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.